A small circle.
A large opportunity.
Averra is being built quietly with a small group of clinicians, scientists and operators. If your work belongs near this — as an investor, a research partner, a clinical collaborator, or otherwise — we'd like to read it in your own words.
Direct.
For anything that doesn't fit the boxes below — a thought, a referral, a question we should be asking. Read by the founding team.
Investors.
Series-stage capital and strategic partners taking a long view of health intelligence. Materials shared under NDA.
Clinical & research.
Hospitals, longevity clinics, research groups, and individual clinicians. Pilots, co-authorship, and federated cohorts.
Press.
Background, founder interviews, and embargoed material. We respond to outlets covering health, technology, and policy.
A note,
and we'll reply.
We read every message ourselves. A line or two is enough — we'll come back with the right thread, the right person, and a real answer rather than a queue ticket.
Received. Thank you.
We read every message ourselves and will write back from a real address within two working days.